168.42
price down icon0.10%   -0.17
after-market After Hours: 168.42
loading
Becton Dickinson Co stock is traded at $168.42, with a volume of 5.09M. It is down -0.10% in the last 24 hours and down -4.67% over the past month. Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$168.59
Open:
$169.31
24h Volume:
5.09M
Relative Volume:
1.78
Market Cap:
$49.98B
Revenue:
$20.87B
Net Income/Loss:
$1.50B
P/E Ratio:
32.14
EPS:
5.24
Net Cash Flow:
$2.59B
1W Performance:
-2.20%
1M Performance:
-4.67%
6M Performance:
-26.03%
1Y Performance:
-29.35%
1-Day Range:
Value
$168.08
$169.96
1-Week Range:
Value
$168.08
$173.44
52-Week Range:
Value
$163.33
$251.99

Becton Dickinson Co Stock (BDX) Company Profile

Name
Name
Becton Dickinson Co
Name
Phone
(201) 847-6800
Name
Address
ONE BECTON DR, FRANKLIN LAKES
Name
Employee
74,000
Name
Twitter
@BDandCo
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
BDX's Discussions on Twitter

Compare BDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
168.42 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
509.36 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.40 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
253.68 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
215.82 16.36B 2.90B 467.20M 306.90M 6.37

Becton Dickinson Co Stock (BDX) Upgrades & Downgrades

Date Action Analyst Rating Change
May-22-25 Downgrade Citigroup Buy → Neutral
May-02-25 Downgrade Goldman Buy → Neutral
May-02-25 Downgrade Piper Sandler Overweight → Neutral
May-02-25 Downgrade Raymond James Outperform → Mkt Perform
May-01-25 Downgrade BofA Securities Buy → Neutral
May-01-25 Downgrade Wells Fargo Overweight → Equal Weight
May-01-25 Downgrade William Blair Outperform → Mkt Perform
Oct-01-24 Upgrade Citigroup Neutral → Buy
May-30-24 Initiated Goldman Buy
Jul-24-23 Upgrade Raymond James Mkt Perform → Outperform
May-30-23 Resumed Morgan Stanley Overweight
May-05-23 Upgrade Piper Sandler Neutral → Overweight
Apr-12-23 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jan-03-23 Upgrade BofA Securities Neutral → Buy
Dec-12-22 Upgrade Citigroup Sell → Neutral
Jul-11-22 Downgrade Citigroup Neutral → Sell
Jun-24-22 Upgrade Wells Fargo Equal Weight → Overweight
Mar-18-22 Resumed Raymond James Mkt Perform
Mar-02-22 Resumed BofA Securities Neutral
Dec-08-21 Downgrade Piper Sandler Overweight → Neutral
Aug-06-21 Downgrade JP Morgan Overweight → Neutral
May-25-21 Initiated Barclays Equal Weight
Dec-15-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-15-20 Downgrade Wells Fargo Overweight → Equal Weight
Jul-09-20 Upgrade Barclays Equal Weight → Overweight
Jun-01-20 Resumed Goldman Buy
Mar-05-20 Initiated Citigroup Neutral
Feb-07-20 Downgrade Cowen Outperform → Market Perform
Feb-07-20 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20 Downgrade Raymond James Strong Buy → Outperform
Feb-06-20 Downgrade Cowen Outperform → Market Perform
Jan-08-20 Downgrade Barclays Overweight → Equal Weight
May-13-19 Upgrade Barclays Equal Weight → Overweight
Dec-07-18 Initiated Deutsche Bank Buy
Oct-16-18 Initiated Barclays Equal Weight
Jun-21-18 Upgrade JP Morgan Neutral → Overweight
Apr-10-18 Upgrade Citigroup Neutral → Buy
Jan-19-18 Resumed BofA/Merrill Buy
Jan-05-18 Upgrade Citigroup Sell → Neutral
Jan-05-18 Initiated KeyBanc Capital Mkts Overweight
Jan-03-18 Initiated Evercore ISI Outperform
Dec-29-17 Reiterated Deutsche Bank Buy
View All

Becton Dickinson Co Stock (BDX) Latest News

pulisher
Jun 18, 2025

YieldBoost Becton, Dickinson From 2.5% To 15.5% Using Options - Nasdaq

Jun 18, 2025
pulisher
Jun 16, 2025

BD upgrades laboratory in Suzhou - China Daily

Jun 16, 2025
pulisher
Jun 14, 2025

Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift - Investing.com

Jun 14, 2025
pulisher
Jun 14, 2025

Becton Dickinson’s SWOT analysis: medical giant’s stock faces pivotal shift By Investing.com - Investing.com India

Jun 14, 2025
pulisher
Jun 13, 2025

Becton Dickinson Stock Price, Quotes and Forecasts | NYSE:BDX - Benzinga

Jun 13, 2025
pulisher
Jun 11, 2025

Medical technology firm BD looks to bring products to more PHL hospitals - BusinessWorld Online

Jun 11, 2025
pulisher
Jun 09, 2025

Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Becton Dickinson at Goldman Sachs Conference: Strategic Moves Ahead - Investing.com Australia

Jun 09, 2025
pulisher
Jun 09, 2025

Becton, Dickinson And Co To Present At Goldman Sachs Conference; Webcast At 2:00 PM ET - Nasdaq

Jun 09, 2025
pulisher
Jun 09, 2025

Stifel maintains Becton Dickinson stock with a $224 target - Investing.com

Jun 09, 2025
pulisher
Jun 08, 2025

Here's How You Can Earn $100 In Passive Income By Investing In Becton Dickinson Stock - Yahoo Finance

Jun 08, 2025
pulisher
Jun 06, 2025

Barclays Lowers Becton, Dickinson & Co. (BDX) Price Target, Maintains Overweight Rating - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Clinical Laboratory Molecular Diagnostics for Infectious Disease Market Research 2025-2029: Biotechnology and Genomics Drive Advancements, Impact of Multiplex Assays in Diagnosis and Treatment - GlobeNewswire Inc.

Jun 06, 2025
pulisher
Jun 05, 2025

BD’s Future Plans: Shed Life Sciences to Fund Medical Technology - Lab Manager

Jun 05, 2025
pulisher
Jun 05, 2025

How Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks? - Barchart.com

Jun 05, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Maintains Overweight Rating Despite Price Target Cut | BDX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays lowers Becton Dickinson stock price target to $241 By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays Adjusts Price Target on Becton, Dickinson and Company to $241 From $261 - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Barclays lowers Becton Dickinson stock price target to $241 - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Receives Adjusted Price Target from Barcl - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson and : BD Vascular Access Management Recognized with Seal of Approval from Infusion Nurses Society - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson (BDX) Receives Adjusted Price Target from Barclays | BDX Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Becton Dickinson EVP David Shan Sells Shares and Other Important Updates - TradingView

Jun 03, 2025
pulisher
Jun 02, 2025

Insider Sell: David Shan Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus

Jun 02, 2025
pulisher
May 28, 2025

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow

May 28, 2025
pulisher
May 28, 2025

Targeted Drug Delivery Research Business Analysis Report 2024-2030 with Focus on 30+ Key Players Such as AbbVie, Amgen, AstraZeneca, Becton Dickinson and Co, & Bristol-Myers Squibb - GlobeNewswire

May 28, 2025
pulisher
May 28, 2025

Becton, Dickinson and Company to Initiate Real-World Patient Data Registry for the Rotarex?? Atherectomy System in Treatment of Peripheral Artery Disease - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease - Becton Dickinson

May 28, 2025
pulisher
May 27, 2025

Becton Dickinson’s SWOT analysis: stock’s future hangs on life sciences spin-off - Investing.com

May 27, 2025
pulisher
May 27, 2025

Saudi Arabia Research Antibodies Market Report 2025-2030, - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Saudi Arabia Research Antibodies Market Report 2025-2030, Competitive Analysis of Cell Signaling Technology, Salima Trading, AJ Jeel Medical & Trading Co, Becton, Dickinson and Co, and Merck - Yahoo Finance

May 27, 2025
pulisher
May 25, 2025

AC Health, Becton Dickinson team up to elevate healthcare standards across Asia - Bilyonaryo Business News

May 25, 2025
pulisher
May 22, 2025

Becton Dickinson stock rating cut by Citi to Neutral, target to $185 - Investing.com India

May 22, 2025
pulisher
May 22, 2025

Becton, Dickinson & Co (BDX) Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView

May 22, 2025
pulisher
May 22, 2025

Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Receives Downgrade and Price Target Cut b - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Receives Downgrade and Price Target Cut by Citigroup | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

6 Analysts Have This To Say About Becton Dickinson - Benzinga

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi to Neutral | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi Amid Quarterly Challen - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Becton Dickinson (BDX) Downgraded by Citi Amid Quarterly Challenges | BDX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citigroup Downgrades Becton Dickinson and Co. to Neutral From Buy, Adjusts PT to $185 From $217 - marketscreener.com

May 22, 2025
pulisher
May 21, 2025

BD aims to secure slice of medical technology market - BusinessMirror

May 21, 2025
pulisher
May 21, 2025

Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs' - BD Newsroom

May 21, 2025
pulisher
May 19, 2025

Employees return to work at North Canaan plant where suspicious package was delivered, officials say - CT Insider

May 19, 2025
pulisher
May 16, 2025

FBI probes North Canaan suspicious package that contaminated hundreds: What we know and don't know - CT Insider

May 16, 2025
pulisher
May 16, 2025

Becton, Dickinson and Company Stock: Analyst Estimates & Ratings - inkl

May 16, 2025
pulisher
May 15, 2025

Becton, Dickinson and Company (BDX): Among the Most Oversold Stocks to Buy According to Billionaires - Insider Monkey

May 15, 2025
pulisher
May 15, 2025

Health dept. clears BD to reopen facility after hazmat scare - The Lakeville Journal

May 15, 2025
pulisher
May 15, 2025

Argus Adjusts Price Target on Becton Dickinson and Co. to $220 From $270, Maintains Buy Rating - marketscreener.com

May 15, 2025

Becton Dickinson Co Stock (BDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_instruments_supplies ALC
$85.40
price up icon 0.74%
medical_instruments_supplies RMD
$253.68
price up icon 1.12%
medical_instruments_supplies WST
$215.82
price down icon 0.98%
medical_instruments_supplies BAX
$29.99
price up icon 0.64%
$64.48
price up icon 0.80%
Cap:     |  Volume (24h):